NIH Highlighted Topic: Tackling Acquisition of Language in Kids (TALK)
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The National Institutes of Health (NIH) is encouraging innovative research proposals focused on understanding, evaluating, and improving outcomes for children with late language emergence, commonly referred to as “late talking.” This highlighted topic supports multidisciplinary research aimed at advancing knowledge of early language development trajectories, identifying predictive factors for long-term outcomes, and developing more effective interventions and support systems for children experiencing language delays.
Late talking affects approximately 10% to 20% of children and may occur alongside conditions such as autism, speech-motor disorders, sensory disorders, developmental disabilities, or without any known underlying condition. NIH is particularly interested in projects that improve understanding of developmental variability, language recovery pathways, persistent language disorders, and the impact of social, cultural, and environmental factors on communication outcomes.
Companies developing speech and language technologies, AI-enabled developmental assessment platforms, digital therapeutics, augmentative and alternative communication (AAC) tools, predictive analytics systems, educational technologies, caregiver support platforms, or longitudinal child development analytics solutions may be strong candidates for funding.
Areas of interest include longitudinal developmental tracking, predictive modeling, early identification tools, culturally responsive interventions, developmental trajectory analysis, communication assessment technologies, caregiver guidance systems, implementation science, and novel approaches to supporting communication success in children with diverse developmental needs. NIH is also encouraging projects leveraging existing datasets, AI and machine learning, telehealth delivery systems, and scalable digital interventions to improve clinical and community-based support for late-talking children.
Funding is available through the NIH SBIR/STTR Program, which currently provides up to approximately $323,090 for Phase I projects and up to $2,153,927 for Phase II projects, with opportunities for follow-on funding and commercialization support depending on project scope and translational impact.
This highlighted topic is supported primarily by the National Institute on Deafness and Other Communication Disorders (NIDCD) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both of which are seeking transformative innovations that improve childhood language development, developmental trajectory prediction, communication interventions, and long-term developmental outcomes.
How much funding would I receive?
Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.
What could I use the funding for?
Funding may support the research, development, validation, and commercialization of speech and language technologies, developmental assessment tools, AI analytics platforms, AAC systems, and child development intervention solutions related to late talking and language development.
Eligible activities may include:
AI and machine learning platforms for language development prediction and assessment
Speech and language screening and diagnostic technologies
Longitudinal developmental tracking and analytics systems
Augmentative and alternative communication (AAC) technologies
Digital therapeutics and communication intervention platforms
Telehealth and remote speech-language therapy systems
Caregiver guidance, education, and support technologies
Developmental trajectory modeling and predictive analytics tools
Autism, speech-motor, sensory, and developmental disability communication support systems
Culturally and linguistically responsive language assessment platforms
Educational technologies supporting early language acquisition
Natural language processing (NLP) tools for child communication analysis
Early identification and intervention systems for language disorders
Clinical decision support and personalized treatment planning platforms
Community-based and school-based language support technologies
Data integration and enrichment tools for developmental research datasets
Prototype development, translational studies, and clinical validation research
Commercialization planning, implementation scaling, and regulatory preparation activities
Funding may also support personnel, software engineering, cloud infrastructure, AI model development, speech analytics, telehealth deployment, developmental research, data analysis, caregiver engagement, intellectual property protection, regulatory strategy, and commercialization activities necessary to advance a scalable and commercially viable pediatric health or communication technology solution aligned with NIH priorities.
Are there any additional benefits I would receive?
Beyond the formal funding award, awardees gain several strategic advantages:
Government Validation and Credibility:
Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.Enhanced Visibility and Market Recognition:
Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities.Access to the Federal Innovation Ecosystem:
Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.Stronger Commercial and Exit Potential:
By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment.
What is the timeline to apply and when would I receive funding?
Applications are accepted each year on January 5th, April 5th, and September 5th. Funding is received approximately 9 months after submission.
Where does this funding come from?
Funding comes from the U.S. Department of Health and Human Services, with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.2% for SBIR, 0.45% for STTR) to support small business innovation.
Who is eligible to apply?
Applicants must be U.S. small business concerns (SBCs) that:
Are organized for profit with a U.S. place of business.
Have ≤ 500 employees including affiliates.
Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.
What companies and projects are likely to win?
Projects that demonstrate:
A clear unmet medical or public-health need,
Strong scientific rationale and feasibility,
High commercialization potential, supported by a realistic market and regulatory strategy, and
Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).
Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption.
Are there any restrictions I should know about?
Companies must complete multiple federal registrations (SAM.gov, Grants.gov, eRA Commons, SBA Company Registry) before applying.
Foreign entities are not eligible.
Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation.
How long will it take me to prepare an application?
For a first-time applicant, preparing a competitive submission will likely take 120–200 hours in total.
How can BW&CO help?
Our team specializes in complex federal R&D proposals and can:
Triple your likelihood of success through proven strategy and insider-aligned proposal development
Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations
Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.
